Clozapine is associated with secondary antibody deficiency

BACKGROUND: Schizophrenia affects 1% of the population. Clozapine is the only medication licensed for treatment-resistant schizophrenia and is intensively monitored to prevent harm from neutropenia. Clozapine is also associated with increased risk of pneumonia although the mechanism is poorly unders...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Psychiatry
Main Authors: Ponsford, Mark, Castle, Daniel, Tahir, Tayyeb, Robinson, Rebecca, Wade, Wendy, Steven, Rachael, Bramhall, Kathryn, Moody, Mo, Carne, Emily, Ford, Catherine, Farewell, Daniel, Williams, Paul, El-Shanawany, Tariq, Jolles, Stephen
Formato: Artigo
Idioma:Inglês
Publicado em: Cambridge University Press 2019
Assuntos:
Papers
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6429246/
https://ncbi.nlm.nih.gov/pubmed/30259827
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1192/bjp.2018.152
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados